In the News

This column highlights the new AI4MH initiative in our department, sharing details from the recent inaugural event, at which Dr. Tom Insel served as the kick-off speaker.

Functional connectivity differences in autism mouse models point to two subtypes that correspond to patterns seen in some people with the condition. Kaustubh Supekar, clinical associate professor of psychiatry and behavioral sciences, provides comment.

The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treatment-resistant major depressive disorder has now demonstrated promise for reducing depressive symptoms of bipolar I disorder in an open-label feasibility and safety trial. Nolan Williams, associate professor of psychiatry and behavioral sciences, is mentioned.

Stanford researchers found that a single dose of ibogaine may dramatically reduce PTSD and TBI symptoms in veterans—offering hope where current U.S. treatments fall short. Nolan Williams, associate professor of psychiatry and behavioral sciences, is featured on the subject.

A new Assembly Bill 384, or the Mental Health Protection Act, would prevent private and public health insurance plans from requiring prior authorizations in order for a patient to be admitted to a 24-hour care center during a crisis. Parnika Saxena, clinical associate professor of psychiatry and behavioral sciences, provides comment.